Bronchodilator reversibility, body plethysmographic phenotypes, and mortality in patients with COPD or PRISm - Hoheisel, A.; Fahndrich, S.; Salina, A.; Papakonstantinou, E.; Pascarella, M.; Grize, L.; Stolz, D. (Eur Respir J, 2026)
Keywords: journalArticle; bronchodilating agent; chronic obstructive lung disease; human; letter; mortality; phenotype